Athanor Capital, LP Ironwood Pharmaceuticals Inc Transaction History

Athanor Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $465,663 - $600,870	-45,833 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$9.04 - $11.86 $182,617 - $239,583	-20,201 Reduced 30.59%	45,833 $512,000
Q4 2020 Feb 16, 2021	SELL	$9.05 - $12.2 $340,171 - $458,573	-37,588 Reduced 36.27%	66,034 $752,000
Q3 2020 Nov 16, 2020	BUY	$8.99 - $10.74 $213,503 - $255,064	23,749 Added 29.73%	103,622 $932,000
Q2 2020 Aug 13, 2020	BUY	$9.14 - $11.97 $730,039 - $956,079	79,873 New	79,873 $824,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.